CoChat

Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development

Feng, Lei, Wang, Yi, Fu, Yu, Li, Ting, He, Guolin · 2024 · Stem Cell Reviews and Reports

The DOI matches its Crossref record; 213 of the 214 references it cites were found in a registry or an index.

Abstract

Acute liver failure (ALF) results from severe liver damage or end-stage liver disease. It is extremely fatal and causes serious health and economic burdens worldwide. Once ALF occurs, liver transplantation (LT) is the only definitive and recommended treatment; however, LT is limited by the scarcity of liver grafts. Consequently, the clinical use of bioartificial liver (BAL) has been proposed as a treatment strategy for ALF. Human primary hepatocytes are an ideal cell source for these methods. However, their high demand and superior viability prevent their widespread use. Hence, finding alternatives that meet the seed cell quality and quantity requirements is imperative. Stem cells with self-renewing, immunogenic, and differentiative capacities are potential cell sources. MSCs and its secretomes encompass a spectrum of beneficial properties, such as anti-inflammatory, immunomodulatory, anti-ROS (reactive oxygen species), anti-apoptotic, pro-metabolomic, anti-fibrogenesis, and pro-regenerative attributes. This review focused on the recent status and future directions of stem cell-based strategies in BAL for ALF. Additionally, we discussed the opportunities and challenges associated with promoting such strategies for clinical applications.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12015-023-10672-5

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 213 references

Cited by

See all 9

Metadata

Authors
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G.
Affiliations
  • Affiliated Hospital of Guizhou Medical University (CN)
  • Shanxi Medical University (CN)
  • Zhujiang Hospital (CN)
  • Third Affiliated Hospital of Guangzhou Medical University (CN)
Corresponding author
  • Feng, Lei
  • Li, Ting
  • He, Guolin
Venue
Stem Cell Reviews and Reports
Published
2024-01-03
Volume
20
Issue
3
Pages
601-616
ISSN
  • 1550-8943 (ISSN-L)
  • 2629-3269
  • 2629-3277
OpenAlex
W4390571130
Cited by
9
References
214
Citations by year
2025: 5 · 2024: 4
FWCI
0.68
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Stem Cell Reviews and Reports (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (82200702, 82200959)
  • Guangdong Basic and Applied Basic Research Foundation (2020A1515111111)
  • Medical Research Foundation of Guangdong Province (B2022086)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
bioartificial liver, acute liver failure, stem cells, mesenchymal stem cells, stem cell secretome, liver transplantation alternatives, immunomodulation, anti-inflammatory activity, reactive oxygen species, anti-apoptotic effects, regenerative medicine
MeSH terms
Humans, Stem Cells, Liver Transplantation, Liver Failure, Acute, Liver, Artificial, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development. https://app.cochat.ai/papers/10.1007/s12015-023-10672-5
The paper
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024). Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-023-10672-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.